Schedule of computation of basic and diluted earnings per share |
The following table sets forth the income attributable to the Company from continuing operations, net of tax, and the Company’s common shares outstanding, and its participating securities outstanding. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Basic and Diluted EPS | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2024 | | 2025 | | 2024 | | 2025 | | | (in thousands) | Income from continuing operations, net of tax | | $ | 37,638 | | | $ | 57,879 | | | $ | 99,167 | | | $ | 132,611 | | Less: net income attributable to non-controlling interests | | 15,881 | | | 17,308 | | | 34,828 | | | 35,359 | | Income from continuing operations, net of tax, attributable to Select Medical Holdings Corporation’s common stockholders | | 21,757 | | | 40,571 | | | 64,339 | | | 97,252 | | Less: distributed and undistributed net income attributable to participating securities | | 932 | | | 820 | | | 2,508 | | | 1,965 | | Distributed and undistributed income from continuing operations, net of tax, attributable to common shares | | $ | 20,825 | | | $ | 39,751 | | | $ | 61,831 | | | $ | 95,287 | |
The following tables set forth the computation of EPS under the two-class method: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | | 2024 | | | 2025 | | | Income from Continuing Operations, Net of Tax, Allocation | | Shares(1) | | Basic and Diluted EPS | | | Income from Continuing Operations, Net of Tax, Allocation | | Shares(1) | | Basic and Diluted EPS | | | (in thousands, except for per share amounts) | Common shares | | $ | 20,825 | | | 123,946 | | | $ | 0.17 | | | | $ | 39,751 | | | 123,359 | | | $ | 0.32 | | Participating securities | | 932 | | | 5,550 | | | $ | 0.17 | | | | 820 | | | 2,545 | | | $ | 0.32 | | Total Company | | $ | 21,757 | | | | | | | | $ | 40,571 | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Six Months Ended June 30, | | | 2024 | | | 2025 | | | Income from Continuing Operations, Net of Tax, Allocation | | Shares(1) | | Basic and Diluted EPS | | | Income from Continuing Operations, Net of Tax, Allocation | | Shares(1) | | Basic and Diluted EPS | | | (in thousands, except for per share amounts) | Common shares | | $ | 61,831 | | | 123,902 | | | $ | 0.50 | | | | $ | 95,287 | | | 124,774 | | | $ | 0.76 | | Participating securities | | 2,508 | | | 5,026 | | | $ | 0.50 | | | | 1,965 | | | 2,573 | | | $ | 0.76 | | Total Company | | $ | 64,339 | | | | | | | | $ | 97,252 | | | | | |
_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ (1) Represents the weighted average share count outstanding during the period.
|